Related Experiment Video
Updated: Feb 22, 2026
08:13
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
6.5K
Peripartum Cardiomyopathy: Do Exosomes Play a Role?
Huanyu Gu1, Qiying Dai1,2, Zhuyuan Liu1
1Department of Cardiology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
Advances in Experimental Medicine and Biology
|September 23, 2017
Summary
Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting pregnant women and new mothers. Early detection and exploring new treatments like exosomes are crucial due to its high mortality rate.
Area of Science:
- Cardiology
- Obstetrics
- Maternal Health
Background:
- Peripartum cardiomyopathy (PPCM) is a serious condition involving heart muscle damage.
- It occurs late in pregnancy or postpartum, leading to systolic heart failure.
- PPCM incidence is rising, necessitating increased physician awareness.
Purpose of the Study:
- To review current understanding and research into peripartum cardiomyopathy.
- To highlight the importance of early diagnosis and treatment strategies for PPCM.
Main Methods:
- Literature review of studies on PPCM.
- Analysis of explored diagnostic and therapeutic approaches.
Main Results:
- PPCM is characterized by irreversible cardiomyocyte damage and systolic heart failure.
- Various treatments including anti-viral, anti-inflammatory, and immunosuppression have been investigated.
- Exosome-based therapies show promising potential for PPCM treatment.
Conclusions:
- High clinical suspicion is vital for diagnosing PPCM due to its severity.
- Ongoing research into novel therapies, such as exosomes, is essential for improving PPCM outcomes.
Related Concept Videos
01:36Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
628
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
01:30Cardiomyopathy II: Dilated Cardiomyopathy
634
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
550
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
01:29Cardiomyopathy V: Interprofessional Care
510
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
510
01:25Cardiomyopathy I: Introduction and Classification
675
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
675